Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

United States FDA Clears The REGEN Trial To Test Bioheart's Combination Gene And Stem Cell Therapy In Heart Failure Patients
Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases announced today that the US FDA cleared a phase I clinical trial for MyoCell SDF-1 (Stromal Derived Factor - 1) to treat congestive heart failure. The REGEN trial will enroll 15 patients in a multicenter, randomized, dose escalation study to assess the safety and cardiovascular effects of the implantation of MyoCell SDF-1 in congestive heart failure patients post myocardial infarction(s).
generic viagra online
National Public Health Organizations Brief Capitol Hill On H1N1
The recent H1N1 flu outbreak served as a genuine test of our national public health system"s ability to respond to an emerging public health threat and experts are cautioning that a more severe outbreak could occur in the fall of 2009. Leaders from some of the nation"s foremost public health and medical associations will conduct a briefing for staff members from House and Senate offices on Thursday, May 21, 2009. Speakers will focus on the status of the current public health workforce and efforts needed to sustain workforce capacity to respond to emerging infectious diseases.
News of the day
New Insights Into Health And Environmental Effects Of Carbon Nanoparticles
A new study raises the possibility that flies and other insects that encounter nanomaterial "hot spots," or spills, near manufacturing facilities in the future could pick up and transport nanoparticles on their bodies, transferring the particles to other flies or habitats in the environment. The study on carbon nanoparticles - barely 1/5,000th the width of a human hair - is scheduled for the Aug. 15 issue of ACS" Environmental Science & Technology, a semi-monthly journal.
Medical Devices

VOA News Examines Malaria In Southern Sudan

VOA News examines malaria in southern Sudan. In the region, malaria is "widespread" and accounts for "up to 30 percent of all diseases treated by health facilities." It is the "number one killer of children in southern Sudan," though there are "no reliable statistics on the number in southern Sudan who suffer, or die from, malaria," VOA News reports. After more than two decades of war, "southern Sudan was granted semi-autonomous status for a six-year period" - beginning in 2005 - "until a more permanent solution can be worked out," writes VOA News. The post-war administration is "grappling" with how to develop good health care services in a "vast, re-poor area that is only now beginning to be developed," according to the news service. People who have been diagnosed with malaria sometimes have to walk to the market to buy malaria drugs because drugs and other vital supplies sometimes do not reach the clinic during the rainy season, said Paulino Pitia, acting county medical officer. Last year, the health aid group PSI and the government of southern Sudan distributed one million insecticide-treated nets [ITNs]. As a result, "[a]necdotal evidence" shows that "there are less people presenting in health facilities with fever and suspected malaria," Marcie Cook, country representative for PSI, said. The government of southern Sudan plans to distribute 3 million additional ITNs by the end of this year with support from the Global Fund to Fight AIDS, Tuberculosis and Malaria and PSI. "Health activists say continual support from the Global Fund and donors is needed to diagnose, treat and prevent further deaths from malaria," VOA News writes (Majtenyi, VOA News, 6/24). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009